Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation

Publisher： John Wiley & Sons Inc

E-ISSN： 1398-9995|70|4|443-452

ISSN： 0105-4538

Source： ALLERGY, Vol.70, Iss.4, 2015-04, pp. : 443-452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid‐treated eosinophilic esophagitis

By  

ALLERGY, Vol. 73, Iss. 1, 2018-01 ,pp. : 239-247

John Wiley & Sons Inc

Access to resources Recommend Favorite

Functional Extracellular Eosinophil Granules: A Bomb Caught in a Trap

By  

International Archives of Allergy and Immunology, Vol. 162, Iss. 4, 2013-10 ,pp. : 276-282

Karger

Access to resources Recommend Favorite

Mepolizumab in the treatment of eosinophilic esophagitis

By Ammoury Rana F   Gupta Sandeep K  

Therapy, Vol. 6, Iss. 2, 2009-03 ,pp. : 231-237

Future Medicine

Access to resources Recommend Favorite

Management of eosinophilic esophagitis in children

By Kagalwalla Amir F   Li B UK   Tolia Vasundhara  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 779-784

Future Medicine

Access to resources Recommend Favorite

Fluticasone Furoate Inhibits Cytokine Secretion from Nasal Epithelial Cells and Reduces Eosinophil Survival in an in vitro Model of Eosinophilic Inflammation

By  

International Archives of Allergy and Immunology, Vol. 163, Iss. 3, 2014-03 ,pp. : 225-233

Karger

Access to resources Recommend Favorite